Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Gain Therapeutics Presents Data at 36ᵗʰ EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2
-
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR)
-
Worksport ltd. Announces Production of AL4 Premium Tonneau Cover, Signaling Major Growth Potential
-
Vice President Mike Teresinski to Highlight the Importance of Relationships, Resilience, and Honesty at Broker-Carrier Summit in Fort Worth, TX
-
Envoy Medical to Present at the LD Micro Main Event XVII
-
PharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application
-
Westport to Issue Q3 2024 Financial Results on November 12, 2024
-
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
-
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence
-
Clinical ink Announces the Promotion of John Pappadakis to Chief Commercial Officer and Megan Petrylak to Chief Operating Officer
-
ebankIT Selects MX as Open Banking Partner to Provide Secure Data Access to Financial Institutions in North America
-
Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
-
Voters Express Growing Concerns About Deepfake Technology Ahead of 2024 Elections: Global Survey Reveals Rising Fears
-
Skyharbour Completes Majority Earn-In and Forms Joint-Venture with Rio Tinto at Russell Lake Uranium Project in the Athabasca Basin
-
Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024
-
Ackroo Releases Q3 2024 Financial Results
-
FCCI Insurance Group Deploys Duck Creek Policy with Active Delivery to Modernize Operations and Drive Expansion into the Excess & Surplus Market
-
Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024
-
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics
-
Vistar Media Strengthens Retail Media Focus, Welcomes New Global Head of Retail Media
-
Join LOBO EV Technologies’ Live Investor Webinar and Q&A Session on October 28
-
BairesDev Joins World Economic Forum Global Innovators Community to unlock equal access to economic opportunity
-
PodcastOne to Announce Second Quarter Fiscal Year 2025 Financial Results and Host Investor Webcast on Thursday November 7, 2024
-
JOANN Enters Another Handmade Holiday Season with Expanded Inventory, Lower Prices, and Doorbuster Sales Through December
-
authID Announces Launch of its Biometric Identity Services with Imperial Technologies
-
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001
-
Solutions to stop a global crisis: “Building Safe Futures: Solutions to End Childhood Sexual Violence” provides a roadmap to end childhood sexual violence
-
Music Licensing, Inc. (OTC: SONG) Corrects ROI to 110.43% on 30-Year Royalty Stream Deal Involving Works by Miley Cyrus, Elton John, Lil Nas X, and XXXTENTACION, While Retaining Lifetime Ownership Rig
-
Veriff launches FaceBlock tool for Self-Serve product
-
MasterCraft Boat Holdings, Inc. to Webcast Fiscal First Quarter 2025 Earnings Conference Call Wednesday, November 6, 2024
-
Lulus to Report Third Quarter 2024 Results on November 13, 2024
-
Ferrari Selects Gauzy’s Smart Glass Technology for Serial Production in Its First-Ever SUV
-
red violet to Announce Third Quarter 2024 Financial Results on November 6, 2024
-
Southern Michigan Bancorp, Inc. Announces Third Quarter 2024 Earnings
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 22 10 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 22 10 2024] - (CGWL)
-
Net Asset Value(s)
-
SmartRecruiters: Talent Acquisition Strategies Stunting Business Growth, Survey Finds
-
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
-
Rakovina Therapeutics Announces Initial Drug Candidates from Deep Docking AI Molecule Discovery Platform
-
Analyses from Cognition’s Positive Phase 2 ‘SHINE’ Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease will be Presented in a Podium Presentation at CTAD
-
TC Energy provides results of Series 9 Shares conversion elections
-
United Community Banks, Inc. Reports Third Quarter Results
-
Stock Yards Bancorp Reports Third Quarter Earnings of $29.4 Million or $1.00 Per Diluted Share
-
Watsco Reports Record Sales, Enhanced Operating Efficiency, Strong Cash Flow and Improving Business Trends
-
Amesite Announces Customization for Paid NurseMagic™ Enterprise Licensees
-
Kura Oncology to Present New Data Supporting Combination of KO-2806 with KRAS G12C and Pan-RAS Inhibitors
-
Lilium, GE Aerospace partner to deliver eVTOL flight safety
-
Streamline Health® Adds Quality Module to Existing eValuator Relationship
-
ZenaTech Announces a Software Company Acquisition Adding Significant Capabilities to Building AI Drones
